The Trillium Extracellular Vesicles is now accepting manuscripts for the next issue to be published in Autumn 2021.

If you are interested, please read the information below and send a tentative title and short abstract (100-200 words) to the Editor-in-Chief directly.

The peer-reviewed proceedings of the German Society for Extracellular Vesicles (GSEV)

Editor-in-Chief: Gregor Fuhrmann

View the Editorial Board

ISSN 2698-8739

www.trillium.de

www.gsev.org

Aim and Scope

Trillium Extracellular Vesicles publishes high-quality research and review articles in the broad field of extracellular vesicles. This includes all aspects of extracellular vesicle biology, such as their role in cancer infection, inflammation and other dispositions; extracellular vesicles in physiological homeostasis; extracellular vesicle isolation and characterisation, including technical and methodological papers; extracellular vesicles from mammalian and non-mammalian sources, such as bacteria, fungi, and plants; extracellular vesicles for therapeutic applications, including drug delivery applications; extracellular vesicles in regenerative medicine, and clinical evaluations of extracellular vesicles.

Review process

Submitted manuscripts will undergo a scientific quality and suitability check by the editorial team. The handling editor decides which articles are sent out for peer-review. At least two independent reviewers who submit their comments to the editor and the authors will assess each manuscript. Authors will be given the opportunity to revise their papers and the editor will decide on the suitability to publish.

Benefits to authors

Publications in TEV are at no charge for authors. We also provide other benefits, such as free PDFs, a liberal copyright policy, free print copies of TEV and much more.

Please see our Author guidelines below for information on article types and submission.

Trillium Extracellular Vesicles is published once a year, both in print and online.

If you are interested in publishing with us, contact the Editor-in-Chief (Dr Gregor Fuhrmann) directly.